Pfizer Says Its COVID-19 Pill Is Highly Effective

An experimental antiviral pill appears to work very well at keeping people who are at high risk of severe COVID-19 from being admitted to the hospital and dying, according to the drug's maker, Pfizer.

Related Keywords

United Kingdom ,Stephen Griffin ,Albert Bourla ,Pfizer ,Medscape Coronavirus Resource Center ,University Of Leeds ,Coronavirus Resource ,Positive Interim Analysis ,Antiviral Treatment Candidate Reduced Risk ,Interim Analysis ,Covid 19 Treatment ,Coronavirus ,019 Novel Coronavirus ,019 Ncov ,Uhan Coronavirus ,Uman Coronavirus Hku1 ,Uman Coronavirus Oc43 ,Cov Oc43 ,Uman Coronavirus 229e ,Cov 229e ,Antiviral ,Amciclovir ,Alacyclovir ,Hospitals ,Inpatient Care ,Acute Respiratory Distress Syndrome ,Cute Respiratory Distress Syndrome Ards ,Adult Respiratory Distress Syndrome ,Cards ,Severe Acute Respiratory Syndrome ,